Isabelle Giraudon is a scientific analyst on health consequences related to drug use at the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
She is responsible for two of the five key epidemiological indicators monitored by the agency, the 'Drug-related deaths and mortality' and the ‘Drug-related infectious diseases’. This work includes research on morbidity and fatal overdoses, as well as the analysis of all causes of mortality among problem drug users, through European longitudinal cohort studies (including mortality related suicide, trauma, HIV and hepatitis).
She is also involved in other fields of monitoring and analysing drug-related harms, including in particular infectious diseases, acute emergencies and harms related to new psychoactive substances.
A French national, she studied public health and pharmaco-epidemiology (MSc). She is a graduate of the European Programme for Intervention Epidemiology training (EPIET). Her previous professional experiences were in Africa, France and England (Health Protection Agency, now Public health England), where she worked mainly on viral hepatitis, HIV and in the drugs field
Her previous research work at the national monitoring centre for drugs (OFDT) in France focused on early warning systems and new psychoactive drugs.
